FI71157C - Foerfarande foer framstaellning av (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)-acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat-pentahydrat - Google Patents

Foerfarande foer framstaellning av (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)-acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat-pentahydrat Download PDF

Info

Publication number
FI71157C
FI71157C FI803126A FI803126A FI71157C FI 71157 C FI71157 C FI 71157C FI 803126 A FI803126 A FI 803126A FI 803126 A FI803126 A FI 803126A FI 71157 C FI71157 C FI 71157C
Authority
FI
Finland
Prior art keywords
solution
title compound
stirring
water
carboxylate
Prior art date
Application number
FI803126A
Other languages
English (en)
Finnish (fi)
Other versions
FI71157B (fi
FI803126L (fi
Inventor
Alastair Couper Brodie
Lewis Aubrey Wetherill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI803126L publication Critical patent/FI803126L/fi
Publication of FI71157B publication Critical patent/FI71157B/fi
Application granted granted Critical
Publication of FI71157C publication Critical patent/FI71157C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI803126A 1979-10-02 1980-10-01 Foerfarande foer framstaellning av (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)-acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat-pentahydrat FI71157C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02
GB7934204 1979-10-02

Publications (3)

Publication Number Publication Date
FI803126L FI803126L (fi) 1981-04-03
FI71157B FI71157B (fi) 1986-08-14
FI71157C true FI71157C (fi) 1986-11-24

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803126A FI71157C (fi) 1979-10-02 1980-10-01 Foerfarande foer framstaellning av (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)-acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat-pentahydrat

Country Status (36)

Country Link
US (1) US4329453A (uk)
JP (1) JPS5657791A (uk)
KR (1) KR840001776B1 (uk)
AT (1) AT368161B (uk)
AU (1) AU539519B2 (uk)
BE (1) BE885489A (uk)
BG (1) BG33586A3 (uk)
CA (1) CA1142919A (uk)
CH (1) CH645118A5 (uk)
CS (1) CS214721B2 (uk)
CY (1) CY1338A (uk)
DD (1) DD153376A5 (uk)
DE (1) DE3037102C2 (uk)
DK (1) DK155525C (uk)
EC (1) ECSP941099A (uk)
ES (1) ES495534A0 (uk)
FI (1) FI71157C (uk)
FR (1) FR2466467A1 (uk)
GB (1) GB2063871B (uk)
GR (1) GR69123B (uk)
HK (1) HK78686A (uk)
HU (1) HU184835B (uk)
IT (1) IT1144006B (uk)
KE (1) KE3641A (uk)
MX (1) MX6545E (uk)
MY (1) MY8500315A (uk)
NL (1) NL190329C (uk)
NO (1) NO156246C (uk)
PL (1) PL126606B1 (uk)
PT (1) PT71860B (uk)
RO (1) RO82721B (uk)
SE (1) SE449614B (uk)
SU (1) SU942599A3 (uk)
UA (1) UA7208A1 (uk)
YU (1) YU42357B (uk)
ZA (1) ZA806081B (uk)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
DE3581619D1 (de) * 1984-11-08 1991-03-07 Lilly Co Eli Verfahren zur herstellung von kristallinischem ceftazidime-pentahydrat.
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
ATE76874T1 (de) * 1987-02-02 1992-06-15 Lilly Co Eli Verfahren zur herstellung von ceftazidimepentahydrat.
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
NL190329B (nl) 1993-08-16
FI71157B (fi) 1986-08-14
ECSP941099A (es) 1995-01-16
MX6545E (es) 1985-07-10
AU6288280A (en) 1981-04-09
ATA490080A (de) 1982-01-15
NO156246C (no) 1987-08-19
DE3037102A1 (de) 1981-04-23
SE449614B (sv) 1987-05-11
SE8006861L (sv) 1981-04-03
NO802913L (no) 1981-04-03
DK414780A (da) 1981-04-03
KR830004317A (ko) 1983-07-09
PL227019A1 (uk) 1981-06-05
JPH0128036B2 (uk) 1989-05-31
NO156246B (no) 1987-05-11
PT71860B (en) 1982-04-02
GB2063871B (en) 1983-06-02
AU539519B2 (en) 1984-10-04
HU184835B (en) 1984-10-29
MY8500315A (en) 1985-12-31
DE3037102C2 (de) 1986-04-10
IT8049783A0 (it) 1980-10-01
SU942599A3 (ru) 1982-07-07
GR69123B (uk) 1982-05-03
NL8005443A (nl) 1981-04-06
GB2063871A (en) 1981-06-10
HK78686A (en) 1986-10-24
FR2466467B1 (uk) 1984-02-10
CY1338A (en) 1987-01-16
NL190329C (nl) 1994-01-17
PT71860A (en) 1980-11-01
FI803126L (fi) 1981-04-03
DK155525C (da) 1989-09-04
US4329453A (en) 1982-05-11
CA1142919A (en) 1983-03-15
YU42357B (en) 1988-08-31
YU249780A (en) 1983-02-28
AT368161B (de) 1982-09-27
RO82721B (ro) 1984-10-30
RO82721A (ro) 1984-09-29
JPS5657791A (en) 1981-05-20
PL126606B1 (en) 1983-08-31
ES8106908A1 (es) 1981-09-01
FR2466467A1 (fr) 1981-04-10
ES495534A0 (es) 1981-09-01
DK155525B (da) 1989-04-17
KE3641A (en) 1986-07-11
BG33586A3 (en) 1983-03-15
UA7208A1 (uk) 1995-06-30
BE885489A (fr) 1981-04-01
IT1144006B (it) 1986-10-29
CH645118A5 (de) 1984-09-14
CS214721B2 (en) 1982-05-28
KR840001776B1 (ko) 1984-10-19
DD153376A5 (de) 1982-01-06
ZA806081B (en) 1982-05-26

Similar Documents

Publication Publication Date Title
FI71157B (fi) Foerfarande foer framstaellning av (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)-acetamido/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat-pentahydrat
DE2727753C2 (uk)
DE2462736C2 (de) 7-Aminothiazolylacetamido-3-cephem-4-carbonsäuren und Verfahren zur Herstellung derselben
RU2118959C1 (ru) ГИДРОХЛОРИД 7β-[(Z)-2-(2-АМИНО-4-ТИАЗОЛИЛ)-2-ГИДРОКСИИМИНОАЦЕТАМИДО]-3-(1,2,3-ТРИАЗОЛ-4-ИЛ)-ТИОМЕТИЛТИО-3-ЦЕФЕМ-4-КАРБОНОВОЙ КИСЛОТЫ, ЕГО КРИСТАЛЛОГИДРАТ И СПОСОБ ИХ ПОЛУЧЕНИЯ
JP5852562B2 (ja) 新規なセフェム誘導体
EP0030294B1 (de) Verfahren zur Herstellung von Cephalosporinderivaten; Zwischenprodukte und deren Herstellung
SU753361A3 (ru) Способ получени ненасыщенных производных 7-ациламидо-3-цефем4-карбоновой кислоты или их солей
EP0005830B1 (de) Cephalosporinderivate, deren Herstellung und die entsprechenden pharmazeutischen Präparate
US4467086A (en) Cephalosporin antibiotic
YU81392A (sr) Diasterreoizomeri 3-cefem-4karboksi-1-(izopropoksi karboniloksi)etil-estra i postupak za njihovu proizvodnju
BG60439B2 (bg) Твърда цефалоспоринова сол
DE2739448A1 (de) 7-substituierte aminoacetamido- oxadethiacephalosporine, verfahren zu deren herstellung und deren verwendung bei der behandlung bakterieller erkrankungen
PL132054B1 (en) Process for preparing novel derivatives of cephalosporins substituted in position 3 with heterocyclothiomethyl group
DE2714419C2 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und Arzneimittel
US4058609A (en) 7-Dithioacetamido cephalosporins
CH634326A5 (de) 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung.
US4107440A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US3971779A (en) 7-[2-(5-Amino-1,3,4-thiadiazol-2-ylthio)acetamido]cephalosporins
RU2029549C1 (ru) Антибиотическая композиция
DE2760488C2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3879384A (en) 7-{8 2-(1-and 2 cyclopenten-1-yl)acetamido{9 cephalosporanic acids
GB1566849A (en) 6 - (2 - acylamino - 2 - arylacetamido)penicillanic acids
CH593989A5 (en) Antibacterial cephalosporins - prepd. from amino-tetrazolo-pyridazinyl-thiomethyl-cephem-carboxylic acids
SI8510745A8 (sl) Postopek za pripravo soli-hidratov derivatov cefalosporina
SI7911233A8 (sl) Postopek za pripravo derivatov cefalosporina

Legal Events

Date Code Title Description
MA Patent expired

Owner name: GLAXO GROUP LIMITED